Key facts
- Ceryx Medical’s last known valuation is $16.6M (Jun 2025).
- It has raised $14.2M; the latest was Later Stage VC ($27.1M) in Jun 2025.
- Notable investors include Innovate UK, BGF (Financial Services), Icehouse Ventures, Parkwalk Advisors, UK Research and Innovation — 16 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for Ceryx Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Ceryx Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ceryx Medical
Developer of a novel implantable bioelectronics therapeutic device designed to target and treat heart failure. The company's device uses a chip technology that can mimic nerve centers within the body and help to control a range of autonomic or rhythmical processes such as peristalsis, heart rate, and walking, enabling doctors to restore normal performance where these processes have been affected by disease or injury.
- Sector
- Healthcare
- HQ
- Cardiff, United Kingdom
- Founded
- 2015
- Employees
- 9
- Website
- ceryxmedical.com/
- Ownership
- Privately Held (backing)
Ceryx Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ceryx Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ceryx Medical in its N-PORT filings yet. We sweep new filings monthly.